Postgraduate Year 2 (PGY2) Pediatric Residency Program


Thank you for your interest in our ASHP pre-candidate status post-graduate year two (PGY2) specialty residency in pediatric pharmacy. This innovative, focused residency program is designed to train residents to become confident and competent pharmacists in pediatric care.

Stephanie Hutshell, MS, PharmD
2016-2017 Pediatric Resident
Stephanie Hutsell, MS, PharmD

Pediatric Residency Mission Statement

The mission of the pediatric residency program with an emphasis in hematology/oncology is to train competent, confident and independent clinical pharmacists in a pediatric health-system setting. Through education, multidisciplinary teamwork and research the resident will obtain skills necessary to provide quality pharmaceutical care and function as a clinical pharmacist/specialist in pediatric hematology/oncology.

Program Overview

The post graduate year two (PGY2) pediatric pharmacy residency program at Lucile Packard Children's Hospital Stanford is a specialty second-year post-graduate training program that offers an environment to gain professional competence, expand clinical knowledge and develop a philosophy of pharmacy practice in pediatric hematology/oncology.
The purpose of the PGY2 residency program in pediatrics with emphasis in hematology/oncology is to:

  • To train competent pharmacists and innovative practitioners who can provide comprehensive pharmaceutical care services in a dynamic and challenging environment
  • To develop excellent written and verbal communication skills
  • To train practitioners who can provide accurate and timely drug information related to hematology/oncology
  • To train practitioners who can develop and implement drug policies, and rational, safe and cost-effective drug therapy related to hematology/oncology
  • To educate health care professionals, students, patients and the community about appropriate medication use and safety
  • To train professionals to become leaders within the pharmacy profession

Program Structure

Our philosophy of residency training is to offer practical experiences in diverse, multidisciplinary environments in pediatric hematology/oncology. Our approach in the provision of pharmaceutical care is to provide comprehensive, patient-oriented services. The residency is currently in pre-candidate status for accreditation by the American Society of Health-System Pharmacists (ASHP) and follows the ASHP Residency Learning System (RLS).
The practice model integrates distribution and clinical activities at the patient care level, and is supported by centralized drug distribution, support functions and management systems.
Residents contribute to many clinical activities, including collection of data for Drug Utilization Evaluations (DUEs), in-services to the staff during their clinical rotations and inpatient medication teaching to patients. The formal aspects of the Pharmacy and Therapeutics Committee are coordinated by the Director of Pharmacy and the Associate Director of Pharmacy. In addition to clinical services, the residents serve as preceptors to pharmacy students and post-graduate year one (PGY1) residents completing their clinical clerkships and hematology/oncology rotations throughout the year.

Residency Requirements

  • Complete and present a research project at the Western States Conference
  • Participate in teaching activities with students and monthly journal club meetings
  • Prepare and present drug monographs for the Pharmacy and Therapeutics Committee
  • Provide drug information related to hematology/oncology topics
  • Staff a minimum of 35 shifts during the residency year, including some weekends and holidays
  • Staff a minimum of 5 shifts for each rotation with a staffing component

Stipends and Benefits

Residents receive a competitive annual stipend with full benefits including an excellent healthcare benefits package, voluntary tax-deferred annuity plan and 10 days of paid time off (PTO). Please refer to our ASHP listing for more information.

In addition, residents receive educational leave and a stipend to attend and participate in clinical presentations at a minimum of 2 conferences which may include:

  • The ASHP Midyear Clinical Meeting
  • The Children’s Oncology Group Meeting
  • The Pediatric Pharmacy Advocacy Group Annual Meeting
  • The Western States Residency/Preceptor meeting

Required rotations

  • Hospital Orientation
  • Oncology
  • Pediatric Intensive Care
  • Neonatal Intensive Care
  • General Pediatrics
  • Nutrition Support
  • Pharmacy Practice and Administration (longitudinal)
  • Research (longitudinal)

Elective rotations

  • Home Infusion
  • Solid Organ Transplant
  • Stem Cell Transplant
  • Cardiovascular Intensive Care
  • Infectious Disease
  • Operating Room/Anesthesia
  • Ambulatory Clinic
  • Pharmacy Informatics
  • Emergency Department (if available)
  • Adult Oncology (if available)